A lot's happened since your Dec19 post. Merck has partnered with Qbiotics in a melanoma project. Qbiotics anti-cancer vet drug Stelfonta is on sale. Human trials Phase1/11 are ticking all boxes. Merck wants to put its market-leading keytruda drug up against Qbiotics' tigilanol tiglate (TT). On its own TT Phase1/11 human trials using the bare minimum dose for safety testing it positively affected 27% and completely worked (you have to be careful how to put this) in 18% of cases. The partnership wants to know do the numbers get higher when combined with keytruda. What's the share price now?
- Forums
- ASX - By Stock
- Qbiotics
Qbiotics, page-53
-
- There are more pages in this discussion • 1,188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online